Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-005-9118-3.

Title:
Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer | Breast Cancer Research and Treatment
Description:
Background Several factors may contribute to poorer prognosis for obese breast cancer patients, including unfavorable disease features, the influence of fat on estrogen availability, co-morbidity, and socio-demographic factors. Both obesity and estrogen receptor negative (ER-) tumors are more prevalent in black women than in whites in North America. We evaluated obesity and race in relation to outcomes in women with ER-breast cancer. Methods Among 4077 women from National Surgical Adjuvant Breast and Bowel Project clinical trials for node-negative, ER-breast cancer, we evaluated disease-free survival (DFS) and its constituents (tumor recurrence, contralateral breast cancer (CBC), second primary cancers, deaths prior to these events) and mortality in relation to body mass index (BMI) and race, using statistical modeling to account for other prognostic factors. Results Compared to those of normal weight (BMI≀24.9), DFS hazard was greater for obese (BMI β‰₯ 30) women [hazard ratio (HR)=1.16, 95% confidence interval (CI)=1.01–1.33]. Obesity did not increase recurrence hazard, but did influence CBC (HR=2.08, 95% CI=1.22–3.55 in postmenopausal women) and second cancers (HR=1.49, 95% CI=1.06–2.10). Mortality increased with obesity; when partitioned by likely cause, those with BMI β‰₯ 35.0 had greater risk of non-breast cancer mortality (HR=1.86, 95% CI=1.21–2.84). Relative to whites and adjusted for BMI, black women had greater hazard for DFS (HR=1.17, 95% CI=1.00–1.38), CBC (HR=1.37, 95% CI=0.94–1.99), and non-breast cancer deaths (HR=2.10, 95% CI=1.45–3.03); risk for deaths likely due to breast cancer was closer to that in whites (HR=1.18; 95% CI=0.93–1.50). Conclusions For women with node-negative, ER-breast cancer from clinical trials, obesity did not increase recurrence risk, but was associated with greater risk for second cancers, CBC, and mortality, particularly non-breast cancer deaths. Less favorable prognosis for black women persists in clinical trials, and is in part attributable to non-breast cancer outcomes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Health & Fitness
  • Education
  • Science

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't tell how the site generates income.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {πŸ”}

cancer, breast, google, scholar, article, pubmed, cas, women, obesity, estrogen, adjuvant, clin, weight, oncol, dignam, factors, body, risk, prognosis, res, usa, research, treatment, race, national, survival, health, carcinoma, nodenegative, clinical, fisher, anderson, patients, black, trials, mass, bmi, access, epidemiol, treat, natl, group, privacy, cookies, content, receptornegative, james, johnson, wickerham, receptor,

Topics {βœ’οΈ}

gov/topics/obesity/calltoaction/calltoaction month download article/chapter pre-morbid body-mass-index estrogen-receptor-negative tumors estrogen receptor-negative tumors node-positive breast cancer node-negative breast cancer early-stage breast cancer cell cycle-regulatory proteins estrogen receptor negative racial/ethnic groups cancer92 southwest oncology group systemic adjuvant therapy young african-american women progesterone receptor status evaluated disease-free survival public health service breast cancer patients breast cancer prognosis lymph node-negative full article pdf prospective cohort studies african american/white differences breast cancer risk randomized clinical trials privacy choices/manage cookies axillary node-negative contralateral breast cancer operable breast cancer national cancer institute natl cancer inst95 natl cancer inst89 natl cancer inst88 natl cancer inst86 endogenous estrogen concentrations er-breast cancer breast cancer deaths breast cancer mortality breast cancer diagnosis ann oncol15 nci-u10-ca-69651 nci-u10-ca-12027 nci p30-ca-14599 breast cancer outcomes ethnicity related differences body mass index black women persists increase recurrence risk article dignam african-american women

Questions {❓}

  • Lee CW, Norris B, Moravan V, Olivotto I, Does body mass index influence the effectiveness of adjuvant tamoxifen in postmenopausal women with early stage breast cancer?
  • Madarnas Y, Sawka CA, Franssen E, Bjarnason GA, Are medical oncologists biased in their treatment of the large woman with breast cancer?
  • Remington RD, Who should code cause of death in a clinical trial?
  • What have we learned from clinical studies?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer
         description:Several factors may contribute to poorer prognosis for obese breast cancer patients, including unfavorable disease features, the influence of fat on estrogen availability, co-morbidity, and socio-demographic factors. Both obesity and estrogen receptor negative (ER-) tumors are more prevalent in black women than in whites in North America. We evaluated obesity and race in relation to outcomes in women with ER-breast cancer. Among 4077 women from National Surgical Adjuvant Breast and Bowel Project clinical trials for node-negative, ER-breast cancer, we evaluated disease-free survival (DFS) and its constituents (tumor recurrence, contralateral breast cancer (CBC), second primary cancers, deaths prior to these events) and mortality in relation to body mass index (BMI) and race, using statistical modeling to account for other prognostic factors. Compared to those of normal weight (BMI≀24.9), DFS hazard was greater for obese (BMI β‰₯ 30) women [hazard ratio (HR)=1.16, 95% confidence interval (CI)=1.01–1.33]. Obesity did not increase recurrence hazard, but did influence CBC (HR=2.08, 95% CI=1.22–3.55 in postmenopausal women) and second cancers (HR=1.49, 95% CI=1.06–2.10). Mortality increased with obesity; when partitioned by likely cause, those with BMI β‰₯ 35.0 had greater risk of non-breast cancer mortality (HR=1.86, 95% CI=1.21–2.84). Relative to whites and adjusted for BMI, black women had greater hazard for DFS (HR=1.17, 95% CI=1.00–1.38), CBC (HR=1.37, 95% CI=0.94–1.99), and non-breast cancer deaths (HR=2.10, 95% CI=1.45–3.03); risk for deaths likely due to breast cancer was closer to that in whites (HR=1.18; 95% CI=0.93–1.50). For women with node-negative, ER-breast cancer from clinical trials, obesity did not increase recurrence risk, but was associated with greater risk for second cancers, CBC, and mortality, particularly non-breast cancer deaths. Less favorable prognosis for black women persists in clinical trials, and is in part attributable to non-breast cancer outcomes.
         datePublished:2005-12-06T00:00:00Z
         dateModified:2005-12-06T00:00:00Z
         pageStart:245
         pageEnd:254
         sameAs:https://doi.org/10.1007/s10549-005-9118-3
         keywords:
            competing risks
            black women
            estrogen receptor negative
            obesity
            prognosis
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:97
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:James J. Dignam
               affiliation:
                     name:The University of Chicago
                     address:
                        name:Department of Health Studies, The University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
                     name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center
                     address:
                        name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
                     name:The University of Chicago
                     address:
                        name:Department of Health Studies, The University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Kelly Wieand
               affiliation:
                     name:The University of Chicago
                     address:
                        name:Department of Health Studies, The University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karen A. Johnson
               affiliation:
                     name:National Cancer Institute
                     address:
                        name:Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter Raich
               affiliation:
                     name:AMC Cancer Research Center and University of Colorado Health Sciences Center
                     address:
                        name:AMC Cancer Research Center and University of Colorado Health Sciences Center, Denver, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stewart J. Anderson
               affiliation:
                     name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center
                     address:
                        name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Pittsburgh
                     address:
                        name:University of Pittsburgh, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carol Somkin
               affiliation:
                     name:Kaiser Permanente Division of Research
                     address:
                        name:Kaiser Permanente Division of Research, Oakland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Lawrence Wickerham
               affiliation:
                     name:NSABP Operations Center and Allegheny General Hospital
                     address:
                        name:NSABP Operations Center and Allegheny General Hospital, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer
      description:Several factors may contribute to poorer prognosis for obese breast cancer patients, including unfavorable disease features, the influence of fat on estrogen availability, co-morbidity, and socio-demographic factors. Both obesity and estrogen receptor negative (ER-) tumors are more prevalent in black women than in whites in North America. We evaluated obesity and race in relation to outcomes in women with ER-breast cancer. Among 4077 women from National Surgical Adjuvant Breast and Bowel Project clinical trials for node-negative, ER-breast cancer, we evaluated disease-free survival (DFS) and its constituents (tumor recurrence, contralateral breast cancer (CBC), second primary cancers, deaths prior to these events) and mortality in relation to body mass index (BMI) and race, using statistical modeling to account for other prognostic factors. Compared to those of normal weight (BMI≀24.9), DFS hazard was greater for obese (BMI β‰₯ 30) women [hazard ratio (HR)=1.16, 95% confidence interval (CI)=1.01–1.33]. Obesity did not increase recurrence hazard, but did influence CBC (HR=2.08, 95% CI=1.22–3.55 in postmenopausal women) and second cancers (HR=1.49, 95% CI=1.06–2.10). Mortality increased with obesity; when partitioned by likely cause, those with BMI β‰₯ 35.0 had greater risk of non-breast cancer mortality (HR=1.86, 95% CI=1.21–2.84). Relative to whites and adjusted for BMI, black women had greater hazard for DFS (HR=1.17, 95% CI=1.00–1.38), CBC (HR=1.37, 95% CI=0.94–1.99), and non-breast cancer deaths (HR=2.10, 95% CI=1.45–3.03); risk for deaths likely due to breast cancer was closer to that in whites (HR=1.18; 95% CI=0.93–1.50). For women with node-negative, ER-breast cancer from clinical trials, obesity did not increase recurrence risk, but was associated with greater risk for second cancers, CBC, and mortality, particularly non-breast cancer deaths. Less favorable prognosis for black women persists in clinical trials, and is in part attributable to non-breast cancer outcomes.
      datePublished:2005-12-06T00:00:00Z
      dateModified:2005-12-06T00:00:00Z
      pageStart:245
      pageEnd:254
      sameAs:https://doi.org/10.1007/s10549-005-9118-3
      keywords:
         competing risks
         black women
         estrogen receptor negative
         obesity
         prognosis
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:97
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:James J. Dignam
            affiliation:
                  name:The University of Chicago
                  address:
                     name:Department of Health Studies, The University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
                  name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center
                  address:
                     name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
                  name:The University of Chicago
                  address:
                     name:Department of Health Studies, The University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Kelly Wieand
            affiliation:
                  name:The University of Chicago
                  address:
                     name:Department of Health Studies, The University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karen A. Johnson
            affiliation:
                  name:National Cancer Institute
                  address:
                     name:Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter Raich
            affiliation:
                  name:AMC Cancer Research Center and University of Colorado Health Sciences Center
                  address:
                     name:AMC Cancer Research Center and University of Colorado Health Sciences Center, Denver, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stewart J. Anderson
            affiliation:
                  name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center
                  address:
                     name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Pittsburgh
                  address:
                     name:University of Pittsburgh, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carol Somkin
            affiliation:
                  name:Kaiser Permanente Division of Research
                  address:
                     name:Kaiser Permanente Division of Research, Oakland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Lawrence Wickerham
            affiliation:
                  name:NSABP Operations Center and Allegheny General Hospital
                  address:
                     name:NSABP Operations Center and Allegheny General Hospital, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:97
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Chicago
      address:
         name:Department of Health Studies, The University of Chicago, Chicago, USA
         type:PostalAddress
      name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center
      address:
         name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
         type:PostalAddress
      name:The University of Chicago
      address:
         name:Department of Health Studies, The University of Chicago, Chicago, USA
         type:PostalAddress
      name:The University of Chicago
      address:
         name:Department of Health Studies, The University of Chicago, Chicago, USA
         type:PostalAddress
      name:National Cancer Institute
      address:
         name:Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
         type:PostalAddress
      name:AMC Cancer Research Center and University of Colorado Health Sciences Center
      address:
         name:AMC Cancer Research Center and University of Colorado Health Sciences Center, Denver, USA
         type:PostalAddress
      name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center
      address:
         name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh
      address:
         name:University of Pittsburgh, Pittsburgh, USA
         type:PostalAddress
      name:Kaiser Permanente Division of Research
      address:
         name:Kaiser Permanente Division of Research, Oakland, USA
         type:PostalAddress
      name:NSABP Operations Center and Allegheny General Hospital
      address:
         name:NSABP Operations Center and Allegheny General Hospital, Pittsburgh, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:James J. Dignam
      affiliation:
            name:The University of Chicago
            address:
               name:Department of Health Studies, The University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
            name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center
            address:
               name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
               type:PostalAddress
            type:Organization
            name:The University of Chicago
            address:
               name:Department of Health Studies, The University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Kelly Wieand
      affiliation:
            name:The University of Chicago
            address:
               name:Department of Health Studies, The University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Karen A. Johnson
      affiliation:
            name:National Cancer Institute
            address:
               name:Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
               type:PostalAddress
            type:Organization
      name:Peter Raich
      affiliation:
            name:AMC Cancer Research Center and University of Colorado Health Sciences Center
            address:
               name:AMC Cancer Research Center and University of Colorado Health Sciences Center, Denver, USA
               type:PostalAddress
            type:Organization
      name:Stewart J. Anderson
      affiliation:
            name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center
            address:
               name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
               type:PostalAddress
            type:Organization
            name:University of Pittsburgh
            address:
               name:University of Pittsburgh, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Carol Somkin
      affiliation:
            name:Kaiser Permanente Division of Research
            address:
               name:Kaiser Permanente Division of Research, Oakland, USA
               type:PostalAddress
            type:Organization
      name:D. Lawrence Wickerham
      affiliation:
            name:NSABP Operations Center and Allegheny General Hospital
            address:
               name:NSABP Operations Center and Allegheny General Hospital, Pittsburgh, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Health Studies, The University of Chicago, Chicago, USA
      name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
      name:Department of Health Studies, The University of Chicago, Chicago, USA
      name:Department of Health Studies, The University of Chicago, Chicago, USA
      name:Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, USA
      name:AMC Cancer Research Center and University of Colorado Health Sciences Center, Denver, USA
      name:National Surgical Adjuvant Breast and Bowel Project (NSABP) Biostatistical Center, Pittsburgh, USA
      name:University of Pittsburgh, Pittsburgh, USA
      name:Kaiser Permanente Division of Research, Oakland, USA
      name:NSABP Operations Center and Allegheny General Hospital, Pittsburgh, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(170)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.39s.